Please enable JavaScript to continue using this application.

Compare $CELU vs $CRVO | Chartloom

Compare

$CELU vs $CRVO

Celularity Inc · CervoMed Inc

CELU

Celularity Inc

CRVO

CervoMed Inc

Compare $CELU vs $CRVO

Comparing Celularity Inc and CervoMed Inc

CELUCelularity Inc

CRVOCervoMed Inc

CELUCelularity Inc

Market cap

$45M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.0%

YTD performance

28.9%

52W performance

-27.4%

FCF yield

-29.3%

CRVOCervoMed Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-95.7%

YTD performance

-58.7%

52W performance

-63.8%

FCF yield

-64.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CELU

CRVO

Detailed metrics comparison

CELU

Celularity Inc

CRVO

CervoMed Inc

Market Cap

CELU$45M

CRVO$44M

Enterprise Value

CELU$87M

CRVO$21M

Price

CELU$1.56

CRVO$3.22

P/E Ratio

CELUN/A

CRVON/A

P/S Ratio

CELU1.70x

CRVO131.50x

EV/Sales

CELU3.27x

CRVO63.70x

EV/EBITDA

CELU0.00x

CRVO0.00x

P/B Ratio

CELU5.88x

CRVO1.99x

P/FCF Ratio

CELUN/A

CRVON/A

EV/FCF

CELU-6.55x

CRVO-0.75x

PEG Ratio

CELUN/A

CRVON/A

Forward P/E (NTM)

CELUN/A

CRVON/A

Forward P/S (NTM)

CELUN/A

CRVON/A

Revenue (TTM)

CELU$27M

CRVO$331K

Revenue Growth (YoY)

CELU-51.0%

CRVO-95.7%

Forward Rev Growth

CELU0.0%

CRVO2153.6%

Gross Margin (TTM)

CELU24.4%

CRVO0.0%

Operating Margin (TTM)

CELU0.0%

CRVO0.0%

EBITDA Margin (TTM)

CELU-203.4%

CRVO-9406.8%

Net Margin (TTM)

CELU-346.0%

CRVO-9160.8%

FCF Margin (TTM)

CELU-49.9%

CRVO-8444.8%

Net Income (TTM)

CELU$-92M

CRVO$-30M

FCF (TTM)

CELU$-13M

CRVO$-28M

EPS (TTM)

CELU-$3.23

CRVO-$2.96

ROE (TTM)

CELU-27244.0%

CRVO-15602.0%

ROA (TTM)

CELU-7794.0%

CRVO-12834.0%

ROIC (TTM)

CELU-9204.0%

CRVO-15602.0%

Cash

CELU$6M

CRVO$22M

Debt

CELU$48M

CRVO$0

Net Cash/Debt

CELU$-42M

CRVO$22M

Current Ratio (TTM)

CELU0.15x

CRVO8.57x

Quick Ratio (TTM)

CELU0.14x

CRVO8.36x

Debt/Equity (TTM)

CELU4.79x

CRVO0.00x

Debt/Assets (TTM)

CELU0.0%

CRVO0.0%

Interest Coverage (TTM)

CELUN/A

CRVON/A

Net Debt/EBITDA (TTM)

CELU0.00x

CRVO0.00x

Beta

CELU0.88

CRVO-0.69

52W Performance

CELU-27.4%

CRVO-63.8%

YTD Performance

CELU28.9%

CRVO-58.7%

% from 52W High

CELU-38.8%

CRVO-67.8%

% from 52W Low

CELU178.5%

CRVO51.2%

Asset Turnover (TTM)

CELU0.23x

CRVO0.07x

FCF Yield (TTM)

CELU-29.3%

CRVO-64.2%

Earnings Yield (TTM)

CELU-203.4%

CRVO-69.7%

Dividend Yield (TTM)

CELUN/A

CRVON/A

Rule of 40

CELU-101.0

CRVO-8,540.5

EV/GP/RG

CELUN/A

CRVON/A

Ticker research

View CELU research View CRVO research

Metric	CELU Celularity Inc	CRVO CervoMed Inc
Market & Valuation
Market Cap	$45M	$44M
Enterprise Value	$87M	$21M
Price	$1.56	$3.22
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	131.50x
EV/Sales	3.27x	63.70x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.88x	1.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.55x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$27M	$331K
Revenue Growth (YoY)	-51.0%	-95.7%
Forward Rev Growth	0.0%	2153.6%
Profitability
Gross Margin (TTM)	24.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-203.4%	-9406.8%
Net Margin (TTM)	-346.0%	-9160.8%
FCF Margin (TTM)	-49.9%	-8444.8%
Net Income (TTM)	$-92M	$-30M
FCF (TTM)	$-13M	$-28M
EPS (TTM)	-$3.23	-$2.96
ROE (TTM)	-27244.0%	-15602.0%
ROA (TTM)	-7794.0%	-12834.0%
ROIC (TTM)	-9204.0%	-15602.0%
Financial Health
Cash	$6M	$22M
Debt	$48M	$0
Net Cash/Debt	$-42M	$22M
Current Ratio (TTM)	0.15x	8.57x
Quick Ratio (TTM)	0.14x	8.36x
Debt/Equity (TTM)	4.79x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	-0.69
52W Performance	-27.4%	-63.8%
YTD Performance	28.9%	-58.7%
% from 52W High	-38.8%	-67.8%
% from 52W Low	178.5%	51.2%
Efficiency & Yields
Asset Turnover (TTM)	0.23x	0.07x
FCF Yield (TTM)	-29.3%	-64.2%
Earnings Yield (TTM)	-203.4%	-69.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-101.0	-8,540.5
EV/GP/RG	N/A	N/A
Ticker research	View CELU research	View CRVO research

Valuation

P/S Ratio

CELU

1.70x

CRVO

131.50x

EV/FCF

CELU

-6.55x

CRVO

-0.75x

Growth & revenue

Revenue Growth TTM

CELU

-51.0%

CRVO

-95.7%

Forward Revenue Growth

CRVO

2153.6%

CELU

0.0%

Profitability & performance

Gross Margin

CELU

24.4%

CRVO

0.0%

ROE

CRVO

-15602.0%

CELU

-27244.0%

FCF Yield %

CELU

-29.3%

CRVO

-64.2%

52-Week Performance

CELU

-27.4%

CRVO

-63.8%

Detailed metrics comparison

CELU

Celularity Inc

CRVO

CervoMed Inc

Market Cap

CELU$45M

CRVO$44M

Enterprise Value

CELU$87M

CRVO$21M

Price

CELU$1.56

CRVO$3.22

P/E Ratio

CELUN/A

CRVON/A

P/S Ratio

CELU1.70x

CRVO131.50x

EV/Sales

CELU3.27x

CRVO63.70x

EV/EBITDA

CELU0.00x

CRVO0.00x

P/B Ratio

CELU5.88x

CRVO1.99x

P/FCF Ratio

CELUN/A

CRVON/A

EV/FCF

CELU-6.55x

CRVO-0.75x

PEG Ratio

CELUN/A

CRVON/A

Forward P/E (NTM)

CELUN/A

CRVON/A

Forward P/S (NTM)

CELUN/A

CRVON/A

Revenue (TTM)

CELU$27M

CRVO$331K

Revenue Growth (YoY)

CELU-51.0%

CRVO-95.7%

Forward Rev Growth

CELU0.0%

CRVO2153.6%

Gross Margin (TTM)

CELU24.4%

CRVO0.0%

Operating Margin (TTM)

CELU0.0%

CRVO0.0%

EBITDA Margin (TTM)

CELU-203.4%

CRVO-9406.8%

Net Margin (TTM)

CELU-346.0%

CRVO-9160.8%

FCF Margin (TTM)

CELU-49.9%

CRVO-8444.8%

Net Income (TTM)

CELU$-92M

CRVO$-30M

FCF (TTM)

CELU$-13M

CRVO$-28M

EPS (TTM)

CELU-$3.23

CRVO-$2.96

ROE (TTM)

CELU-27244.0%

CRVO-15602.0%

ROA (TTM)

CELU-7794.0%

CRVO-12834.0%

ROIC (TTM)

CELU-9204.0%

CRVO-15602.0%

Cash

CELU$6M

CRVO$22M

Debt

CELU$48M

CRVO$0

Net Cash/Debt

CELU$-42M

CRVO$22M

Current Ratio (TTM)

CELU0.15x

CRVO8.57x

Quick Ratio (TTM)

CELU0.14x

CRVO8.36x

Debt/Equity (TTM)

CELU4.79x

CRVO0.00x

Debt/Assets (TTM)

CELU0.0%

CRVO0.0%

Interest Coverage (TTM)

CELUN/A

CRVON/A

Net Debt/EBITDA (TTM)

CELU0.00x

CRVO0.00x

Beta

CELU0.88

CRVO-0.69

52W Performance

CELU-27.4%

CRVO-63.8%

YTD Performance

CELU28.9%

CRVO-58.7%

% from 52W High

CELU-38.8%

CRVO-67.8%

% from 52W Low

CELU178.5%

CRVO51.2%

Asset Turnover (TTM)

CELU0.23x

CRVO0.07x

FCF Yield (TTM)

CELU-29.3%

CRVO-64.2%

Earnings Yield (TTM)

CELU-203.4%

CRVO-69.7%

Dividend Yield (TTM)

CELUN/A

CRVON/A

Rule of 40

CELU-101.0

CRVO-8,540.5

EV/GP/RG

CELUN/A

CRVON/A

Ticker research

View CELU research View CRVO research

Metric	CELU Celularity Inc	CRVO CervoMed Inc
Market & Valuation
Market Cap	$45M	$44M
Enterprise Value	$87M	$21M
Price	$1.56	$3.22
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	131.50x
EV/Sales	3.27x	63.70x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.88x	1.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.55x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$27M	$331K
Revenue Growth (YoY)	-51.0%	-95.7%
Forward Rev Growth	0.0%	2153.6%
Profitability
Gross Margin (TTM)	24.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-203.4%	-9406.8%
Net Margin (TTM)	-346.0%	-9160.8%
FCF Margin (TTM)	-49.9%	-8444.8%
Net Income (TTM)	$-92M	$-30M
FCF (TTM)	$-13M	$-28M
EPS (TTM)	-$3.23	-$2.96
ROE (TTM)	-27244.0%	-15602.0%
ROA (TTM)	-7794.0%	-12834.0%
ROIC (TTM)	-9204.0%	-15602.0%
Financial Health
Cash	$6M	$22M
Debt	$48M	$0
Net Cash/Debt	$-42M	$22M
Current Ratio (TTM)	0.15x	8.57x
Quick Ratio (TTM)	0.14x	8.36x
Debt/Equity (TTM)	4.79x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	-0.69
52W Performance	-27.4%	-63.8%
YTD Performance	28.9%	-58.7%
% from 52W High	-38.8%	-67.8%
% from 52W Low	178.5%	51.2%
Efficiency & Yields
Asset Turnover (TTM)	0.23x	0.07x
FCF Yield (TTM)	-29.3%	-64.2%
Earnings Yield (TTM)	-203.4%	-69.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-101.0	-8,540.5
EV/GP/RG	N/A	N/A
Ticker research	View CELU research	View CRVO research